Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,309,228
-$1,038,892 QoQ
Shares Held
11,900
-21.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#910
of 3,140 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. AMGN ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
151,500 | $28,727,430 | |
| 2 | MRK |
Merck & Co., Inc.
|
213,500 | $27,434,750 | |
| 3 | LLY |
ELI LILLY & Co
|
22,315 | $26,765,282 | |
| 4 | ABBV |
AbbVie Inc.
|
96,775 | $24,352,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
178,250 | $22,520,105 | |
| 6 | BIIB |
Biogen Inc.
|
94,850 | $20,493,291 | |
| 7 | JNJ |
Johnson & Johnson
|
72,500 | $18,412,825 | |
| 8 | AMGN |
Amgen Inc
This page
|
11,900 | $4,309,228 |
All Filings in AMGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,309,228 | 11,900 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,348,120 | 15,200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,783,160 | 36,000 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $1,246,200 | 4,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $781,920 | 3,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $966,630 | 3,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,327,912 | 4,250 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,208,360 | 4,250 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,296,090 | 4,500 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||